The Systemic Sclerosis Heart

Sanjiv J. Shah*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

SSc can affect a variety of cardiac structures: it can cause myocardial abnormalities (including myocardial fibrosis, left ventricular [LV] systolic dysfunction, and LV diastolic dysfunction), coronary microvascular dysfunction, pericardial disease, and electrophysiologic abnormalities, including brady- and tachyarrhythmias. Cardiac involvement in SSc is a leading risk factor for death, and approximately 25% of deaths due to SSc are attributable to primary cardiac causes. It is therefore critical that clinicians involved in the care of SSc, including those conducting hematopoietic stem cell transplantation (HSCT) in SSc, understand the epidemiology, pathophysiology, screening, diagnosis, and management of cardiac manifestations of SSc.

Original languageEnglish (US)
Title of host publicationHematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases
PublisherCRC Press
Pages442-455
Number of pages14
ISBN (Electronic)9781351364768
ISBN (Print)9781032827940
DOIs
StatePublished - Jan 1 2021

ASJC Scopus subject areas

  • General Medicine
  • General Immunology and Microbiology

Fingerprint

Dive into the research topics of 'The Systemic Sclerosis Heart'. Together they form a unique fingerprint.

Cite this